The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Dextrose Injection-Global Market Insights and Sales Trends 2024
Synopsis
Dextrose is also called as glucose as they are chemically identical. It plays a vital role in providing energy to body cells. Dextrose Injection is a non-pyrogenic and sterile solution for caloric supply and fluid replenishment by a single dose. Route of administration of dextrose injection is intravenous i.e. into the vein. Dosage of dextrose injection depends upon weight, age, and clinical condition of the patient. Dextrose 5% in water is injected into the vein to replace lost fluids and also provide carbohydrates to the body. Dextrose 5% in water is also used to treat hypoglycemia (low blood sugar), insulin shock and dehydration (fluid loss). Dextrose is a carbohydrate which is a part of nutrition. Dextrose solution along with amino acids and fats provide nutrition the body. This is called as total parental nutrition. Hyperkalemia is a condition in which potassium levels are high. Dextrose solution (50%) is administered to person suffering from hyperkalemia.
The global Dextrose Injection market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Dextrose Injection in various end use industries. The expanding demands from the First-Aid Treatment, Sports, Trophotherapy and Others, are propelling Dextrose Injection market. 5% Dextrose Injection, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 10% Dextrose Injection segment is estimated at % CAGR for the next seven-year period.
Increasing number of launches pertaining to novel dextrose injection products by key players in the market is expected to drive market growth. For instance in 2018, SteriMAx Inc., engaged in production, development, marketing and distribution of essential hospital and retail pharmacy products, launched new drug Bupivacaine Hydrochloride in 8.25% dextrose injection indicated for spinal anesthesia. It is a subarachnoid injection (spinal block).
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Dextrose Injection, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Dextrose Injection market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Dextrose Injection market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Dextrose Injection sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Dextrose Injection covered in this report include Pfizer, Amphastar, ChanGee, Seqirus, Baxter, Shandong Qidu Pharmaceutical, Sanctus Drugs & Pharmaceuticals, Mountainside Medical and Hospira, etc.
The global Dextrose Injection market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer
Amphastar
ChanGee
Seqirus
Baxter
Shandong Qidu Pharmaceutical
Sanctus Drugs & Pharmaceuticals
Mountainside Medical
Hospira
B Braun
Global Dextrose Injection market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Dextrose Injection market, Segment by Type:
5% Dextrose Injection
10% Dextrose Injection
50% Dextrose Injection
70% Dextrose Injection
Global Dextrose Injection market, by Application
First-Aid Treatment
Sports
Trophotherapy
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Dextrose Injection companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Dextrose is also called as glucose as they are chemically identical. It plays a vital role in providing energy to body cells. Dextrose Injection is a non-pyrogenic and sterile solution for caloric supply and fluid replenishment by a single dose. Route of administration of dextrose injection is intravenous i.e. into the vein. Dosage of dextrose injection depends upon weight, age, and clinical condition of the patient. Dextrose 5% in water is injected into the vein to replace lost fluids and also provide carbohydrates to the body. Dextrose 5% in water is also used to treat hypoglycemia (low blood sugar), insulin shock and dehydration (fluid loss). Dextrose is a carbohydrate which is a part of nutrition. Dextrose solution along with amino acids and fats provide nutrition the body. This is called as total parental nutrition. Hyperkalemia is a condition in which potassium levels are high. Dextrose solution (50%) is administered to person suffering from hyperkalemia.
The global Dextrose Injection market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Dextrose Injection in various end use industries. The expanding demands from the First-Aid Treatment, Sports, Trophotherapy and Others, are propelling Dextrose Injection market. 5% Dextrose Injection, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 10% Dextrose Injection segment is estimated at % CAGR for the next seven-year period.
Increasing number of launches pertaining to novel dextrose injection products by key players in the market is expected to drive market growth. For instance in 2018, SteriMAx Inc., engaged in production, development, marketing and distribution of essential hospital and retail pharmacy products, launched new drug Bupivacaine Hydrochloride in 8.25% dextrose injection indicated for spinal anesthesia. It is a subarachnoid injection (spinal block).
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Dextrose Injection, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Dextrose Injection market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Dextrose Injection market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Dextrose Injection sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Dextrose Injection covered in this report include Pfizer, Amphastar, ChanGee, Seqirus, Baxter, Shandong Qidu Pharmaceutical, Sanctus Drugs & Pharmaceuticals, Mountainside Medical and Hospira, etc.
The global Dextrose Injection market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer
Amphastar
ChanGee
Seqirus
Baxter
Shandong Qidu Pharmaceutical
Sanctus Drugs & Pharmaceuticals
Mountainside Medical
Hospira
B Braun
Global Dextrose Injection market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Dextrose Injection market, Segment by Type:
5% Dextrose Injection
10% Dextrose Injection
50% Dextrose Injection
70% Dextrose Injection
Global Dextrose Injection market, by Application
First-Aid Treatment
Sports
Trophotherapy
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Dextrose Injection companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Dextrose Injection
1.1 Dextrose Injection Market Overview
1.1.1 Dextrose Injection Product Scope
1.1.2 Dextrose Injection Market Status and Outlook
1.2 Global Dextrose Injection Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Dextrose Injection Market Size by Region (2018-2029)
1.4 Global Dextrose Injection Historic Market Size by Region (2018-2023)
1.5 Global Dextrose Injection Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Dextrose Injection Market Size (2018-2029)
1.6.1 North America Dextrose Injection Market Size (2018-2029)
1.6.2 Europe Dextrose Injection Market Size (2018-2029)
1.6.3 Asia-Pacific Dextrose Injection Market Size (2018-2029)
1.6.4 Latin America Dextrose Injection Market Size (2018-2029)
1.6.5 Middle East & Africa Dextrose Injection Market Size (2018-2029)
2 Dextrose Injection Market by Type
2.1 Introduction
2.1.1 5% Dextrose Injection
2.1.2 10% Dextrose Injection
2.1.3 50% Dextrose Injection
2.1.4 70% Dextrose Injection
2.2 Global Dextrose Injection Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Dextrose Injection Historic Market Size by Type (2018-2023)
2.2.2 Global Dextrose Injection Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Dextrose Injection Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Dextrose Injection Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Dextrose Injection Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Dextrose Injection Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Dextrose Injection Revenue Breakdown by Type (2018-2029)
3 Dextrose Injection Market Overview by Application
3.1 Introduction
3.1.1 First-Aid Treatment
3.1.2 Sports
3.1.3 Trophotherapy
3.1.4 Others
3.2 Global Dextrose Injection Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Dextrose Injection Historic Market Size by Application (2018-2023)
3.2.2 Global Dextrose Injection Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Dextrose Injection Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Dextrose Injection Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Dextrose Injection Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Dextrose Injection Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Dextrose Injection Revenue Breakdown by Application (2018-2029)
4 Dextrose Injection Competition Analysis by Players
4.1 Global Dextrose Injection Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Dextrose Injection as of 2022)
4.3 Date of Key Players Enter into Dextrose Injection Market
4.4 Global Top Players Dextrose Injection Headquarters and Area Served
4.5 Key Players Dextrose Injection Product Solution and Service
4.6 Competitive Status
4.6.1 Dextrose Injection Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Pfizer
5.1.1 Pfizer Profile
5.1.2 Pfizer Main Business
5.1.3 Pfizer Dextrose Injection Products, Services and Solutions
5.1.4 Pfizer Dextrose Injection Revenue (US$ Million) & (2018-2023)
5.1.5 Pfizer Recent Developments
5.2 Amphastar
5.2.1 Amphastar Profile
5.2.2 Amphastar Main Business
5.2.3 Amphastar Dextrose Injection Products, Services and Solutions
5.2.4 Amphastar Dextrose Injection Revenue (US$ Million) & (2018-2023)
5.2.5 Amphastar Recent Developments
5.3 ChanGee
5.3.1 ChanGee Profile
5.3.2 ChanGee Main Business
5.3.3 ChanGee Dextrose Injection Products, Services and Solutions
5.3.4 ChanGee Dextrose Injection Revenue (US$ Million) & (2018-2023)
5.3.5 Seqirus Recent Developments
5.4 Seqirus
5.4.1 Seqirus Profile
5.4.2 Seqirus Main Business
5.4.3 Seqirus Dextrose Injection Products, Services and Solutions
5.4.4 Seqirus Dextrose Injection Revenue (US$ Million) & (2018-2023)
5.4.5 Seqirus Recent Developments
5.5 Baxter
5.5.1 Baxter Profile
5.5.2 Baxter Main Business
5.5.3 Baxter Dextrose Injection Products, Services and Solutions
5.5.4 Baxter Dextrose Injection Revenue (US$ Million) & (2018-2023)
5.5.5 Baxter Recent Developments
5.6 Shandong Qidu Pharmaceutical
5.6.1 Shandong Qidu Pharmaceutical Profile
5.6.2 Shandong Qidu Pharmaceutical Main Business
5.6.3 Shandong Qidu Pharmaceutical Dextrose Injection Products, Services and Solutions
5.6.4 Shandong Qidu Pharmaceutical Dextrose Injection Revenue (US$ Million) & (2018-2023)
5.6.5 Shandong Qidu Pharmaceutical Recent Developments
5.7 Sanctus Drugs & Pharmaceuticals
5.7.1 Sanctus Drugs & Pharmaceuticals Profile
5.7.2 Sanctus Drugs & Pharmaceuticals Main Business
5.7.3 Sanctus Drugs & Pharmaceuticals Dextrose Injection Products, Services and Solutions
5.7.4 Sanctus Drugs & Pharmaceuticals Dextrose Injection Revenue (US$ Million) & (2018-2023)
5.7.5 Sanctus Drugs & Pharmaceuticals Recent Developments
5.8 Mountainside Medical
5.8.1 Mountainside Medical Profile
5.8.2 Mountainside Medical Main Business
5.8.3 Mountainside Medical Dextrose Injection Products, Services and Solutions
5.8.4 Mountainside Medical Dextrose Injection Revenue (US$ Million) & (2018-2023)
5.8.5 Mountainside Medical Recent Developments
5.9 Hospira
5.9.1 Hospira Profile
5.9.2 Hospira Main Business
5.9.3 Hospira Dextrose Injection Products, Services and Solutions
5.9.4 Hospira Dextrose Injection Revenue (US$ Million) & (2018-2023)
5.9.5 Hospira Recent Developments
5.10 B Braun
5.10.1 B Braun Profile
5.10.2 B Braun Main Business
5.10.3 B Braun Dextrose Injection Products, Services and Solutions
5.10.4 B Braun Dextrose Injection Revenue (US$ Million) & (2018-2023)
5.10.5 B Braun Recent Developments
6 North America
6.1 North America Dextrose Injection Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Dextrose Injection Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Dextrose Injection Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Dextrose Injection Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Dextrose Injection Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Dextrose Injection Market Dynamics
11.1 Dextrose Injection Industry Trends
11.2 Dextrose Injection Market Drivers
11.3 Dextrose Injection Market Challenges
11.4 Dextrose Injection Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
